Dianthus Therapeutics Inc. (DNTH)
NASDAQ · Healthcare
Dianthus Therapeutics Inc. Net Income 2016–2025
Dianthus Therapeutics Inc. annual/quarterly net income history and growth rate from 2016 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Dianthus Therapeutics Inc. net income for the quarter ending September 30, 2025 was -36.8 M, a 46.04% increase year-over-year.
- Dianthus Therapeutics Inc. net income for the twelve months ending September 30, 2025 was -123.1 M, a 128.34% increase year-over-year.
- Dianthus Therapeutics Inc. annual net income for 2025 was -162.3 M, a 91.05% increase from 2024.
- Dianthus Therapeutics Inc. annual net income for 2024 was -85.0 M, a 95.08% increase from 2023.
- Dianthus Therapeutics Inc. annual net income for 2023 was -43.6 M, a 43.26% decrease from 2019.
- Dianthus Therapeutics Inc. annual net income for 2019 was -76.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Dianthus Therapeutics Inc. Net Income — FAQ
Dianthus Therapeutics Inc. (DNTH) net income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Dianthus Therapeutics Inc.'s net income?
Dianthus Therapeutics Inc. (DNTH) reported net income of -$162M for fiscal 2025.
Where can I see DNTH's net income history?
The chart and table above show Dianthus Therapeutics Inc.'s net income by year and by quarter, including the growth rate.